Multiple Sclerosis Clinical Trial

Clinical Trial Finder Multiple Sclerosis Trials

Open-Label Natalizumab Safety Extension Study

See Locations Near You

Summary

The primary objective of this study is to determine the safety and the immunogenicity of extended treatment with natalizumab when administered at a dose of 300 mg intravenously (IV) to subjects with multiple sclerosis (MS) who have completed natalizumab Studies C-1801, C-1802, or C-1803.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Must give written informed consent.
Must be an MS subject who has completed natalizumab Study C-1801, C-1802 or C-1803

Exclusion Criteria:

History of, or available abnormal laboratory results, indicative of any significant disease that would preclude treatment.
History of severe allergic or anaphylactic reactions or known drug hypersensitivity
A clinically significant infectious illness within 30 days prior to study entry.

Study is for people with:

Multiple Sclerosis

Phase:

Phase 3

Estimated Enrollment:

1615

Study ID:

NCT00276172

Recruitment Status:

Completed

Sponsor:

Biogen

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Performed at only C-1801, C-1802, and C-1803 sites globally. No general public enrollment. Biogen Idec is located in
Cambridge Massachusetts, 02142, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Phase:

Phase 3

Estimated Enrollment:

1615

Study ID:

NCT00276172

Recruitment Status:

Completed

Sponsor:


Biogen

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider